Inovio Pharmaceuticals, Inc.INONASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-88.63B
↓ 887% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-8.98B
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-88.63B | -84660.6% |
| 2024 | $-104.56M | +16.1% |
| 2023 | $-124.69M | +42.6% |
| 2022 | $-217.18M | -0.1% |
| 2021 | $-216.94M | -20.9% |
| 2020 | $-179.50M | -81.6% |
| 2019 | $-98.84M | -30.7% |
| 2018 | $-75.64M | -2.9% |
| 2017 | $-73.50M | -10.5% |
| 2016 | $-66.49M | - |